Holdings
GordonMD Global Investments LP
As of Sep 30, 2026, GordonMD Global Investments LP reported 13 positions worth US$151M. Largest: Pyxis Oncology, Inc., Kyverna Therapeutics, Inc. and Celldex Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Pyxis Oncology, Inc. | 15.5M | US$36.2M | +5.52M | Sep 30, 2026 |
| Kyverna Therapeutics, Inc. | 4.52M | US$30.7M | +277K | Sep 30, 2026 |
| Celldex Therapeutics, Inc. | 280K | US$9.07M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 1.85M | US$9.02M | new | Sep 30, 2026 |
| Vir Biotechnology, Inc. | 804K | US$8.98M | −550K | Sep 30, 2026 |
| ADARx Pharmaceuticals, Inc. | 450K | US$8.97M | new | Sep 30, 2026 |
| Allogene Therapeutics, Inc. | 5.3M | US$8.48M | no change | Sep 30, 2026 |
| Bausch + Lomb Corporation | 475K | US$8.08M | −98,000 | Sep 30, 2026 |
| Editas Medicine, Inc. | 3.13M | US$8.04M | no change | Sep 30, 2026 |
| Incyte Corporation | 51,080 | US$6.2M | +7,780 | Sep 30, 2026 |